scholarly journals Topotecan and Doxorubicin Combination to Treat Recurrent Ovarian Cancer: The Influence of Drug Exposure Time and Delivery Systems to Achieve Optimum Therapeutic Activity

2013 ◽  
Vol 19 (4) ◽  
pp. 865-877 ◽  
Author(s):  
Nilesh A. Patankar ◽  
Julia Pritchard ◽  
Mariska van Grinsven ◽  
Maryam Osooly ◽  
Marcel B. Bally
Keyword(s):  
Ovarian Cancer ◽  
Exposure Time ◽  
Drug Exposure ◽  
Recurrent Ovarian Cancer ◽  
Delivery Systems ◽  
Therapeutic Activity

Resource Utilization and Expenditures During the “Watchful Waiting” Period in Patients With Recurrent Ovarian Cancer

2019 ◽  
Vol 5 (1) ◽  
pp. 40-48 ◽  
Author(s):  
Brooke Harrow ◽  
Karin Travers ◽  
Brian M Davis ◽  
Paula Smith ◽  
Adrienne M Gilligan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Resource Utilization ◽  
Watchful Waiting ◽  
Recurrent Ovarian Cancer ◽  
Waiting Period

ROLE OF ULTRASOUND IN THE DETECTION OF RECURRENT OVARIAN CANCER

2020 ◽  
Vol 6 (1) ◽  
pp. 23-31
Author(s):  
M. Alisherova ◽  
◽  
M. Ismailova
Keyword(s):  
Ovarian Cancer ◽  
Surgical Treatment ◽  
Reproductive System ◽  
Malignant Tumors ◽  
Recurrent Ovarian Cancer ◽  
Primary Diagnosis ◽  
Female Reproductive System

Currently, there are no standard approaches to monitoring patients with ovarian cancer (OC). While the role of ultrasound (US) has been identified in the primary diagnosis of OS, it is still controversial during the subsequent surgical treatment of OC. In world statistics, ovarian cancer is consistently among the four main localizations of malignant tumors of the female reproductive system, along with tumors of the breast, body and cervix.

Sign in / Sign up

Export Citation Format

Share Document